Trial · NCT06511791
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.
NCT06511791, Phase 1, Terminated, Ferring Pharmaceuticals
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation. Trials, record NCT06511791. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06511791
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.
- NCT number
- NCT06511791
- Status
- Terminated
- Phases
- Phase 1
- Enrollment
- 106 participants, actual
- Lead sponsor
- Ferring Pharmaceuticals
- Conditions
- Infertility
- Interventions
- FE 999302, Follitropin delta, Placebo FE 999302
- First posted
- 2024-07-22
- Last updated
- 2026-03-30
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of good-quality blastocysts | Day 5 | Number of good-quality blastocysts on day 5 after oocyte retrieval |
| Secondary | Number and Size of Follicles | Day 5 and up to 20 days | Number of follicles by size category on stimulation day 5 and at end-of-stimulation |
| Secondary | Serum hormone concentrations | Day 5, up to 20 days, and up to 22 days | Serum hormone concentrations of progesterone, androstenedione, estradiol, inhibin B, and luteinising hormone (LH). |
| Secondary | Number of Stimulation Days | Up to 20 days | Number of stimulation days |
| Secondary | Number of Oocytes | Up to 22 days | Number of oocytes retrieved |
| Secondary | Number of metaphase II oocytes | Up to 22 days | Number of metaphase II (MII) oocytes |
| Secondary | Number of fertilised oocytes | Up to 22 days | Number of fertilised (2 pronuclei \[2PN\]) oocytes |
| Secondary | Number of blastocysts | Up to 27 days | Number of blastocysts |
| Secondary | Number of cryopreserved blastocysts | Up to 28 days | Number of cryopreserved blastocysts |
| Secondary | Endometrial thickness | Up to 20 days and up to 27 days | Endometrial thickness |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06511791
GET https://conductscience.org/api/trials/v1/NCT06511791/registered